Farringdon Capital’s Boston Scientific BSX Stock Holding History

Farringdon Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.39M	Buy	+38,104	New	+$3.05M	0.52%	52
2025 Q4	–	Sell	-22,570	Closed	-$2.2M	–	460
2025 Q3	$2.2M	Buy	+22,570	New	+$2.34M	0.56%	31
2025 Q2	–	Sell	-2,086	Closed	-$210K	–	445
2025 Q1	$210K	Buy	+2,086	New	+$210K	0.11%	280

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Farringdon Capital's BSX Position: Q1 2026 in Review

Farringdon Capital opened a new position in Boston Scientific (BSX) in Q1 2026: 38,104 shares worth $2.39M. The stake represents 0.52% of the portfolio and ranks #52 among its holdings. This is a return to the name: Farringdon Capital previously reported a position in BSX as recently as Q3 2025.

Farringdon Capital first reported a position in BSX in Q1 2025 and has held it in 3 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Farringdon Capital held 38,104 shares of Boston Scientific worth $2.39M as of Q1 2026.
Boston Scientific was a new Farringdon Capital position in Q1 2026.
Boston Scientific made up 0.52% of Farringdon Capital's portfolio in Q1 2026, its #52 holding.
Farringdon Capital first reported a position in Boston Scientific in Q1 2025 and has held it in 3 quarters since.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.